Disparities in participation in cancer clinical trials in the United States : a symptom of a healthcare system in crisis

Cancer. 2008 Feb 1;112(3):447-54. doi: 10.1002/cncr.23201.

Abstract

Disparities in minorities' representation in cancer clinical trials have been shown only in adult populations, which suggest that the main causes of these disparities relate to health system-based barriers, including issues of poverty (lack of insurance), poor access to trials, and an inadequate number of clinical trials. Initiatives that increase the participation of community physicians in cancer clinical research trials and increase low socioeconomic status patients' access to cancer trials will likely ameliorate this problem.

MeSH terms

  • Clinical Trials as Topic / economics
  • Clinical Trials as Topic / statistics & numerical data
  • Clinical Trials as Topic / trends*
  • Delivery of Health Care / economics
  • Delivery of Health Care / statistics & numerical data
  • Delivery of Health Care / trends*
  • Health Policy
  • Health Services Accessibility
  • Healthcare Disparities / economics
  • Healthcare Disparities / statistics & numerical data
  • Healthcare Disparities / trends*
  • Humans
  • Insurance, Health
  • National Cancer Institute (U.S.)
  • Neoplasms / ethnology*
  • Neoplasms / therapy*
  • Patient Participation / economics
  • Patient Participation / statistics & numerical data
  • Patient Participation / trends*
  • Social Class
  • United States